{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:43:54Z","timestamp":1776224634295,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Construction of key clinical specialties in Shanghai","award":["shslczdzk04801"],"award-info":[{"award-number":["shslczdzk04801"]}]},{"name":"High-level scientific and technological innovation projects combination of medical treatment and health care","award":["YYKC-2021-01-001"],"award-info":[{"award-number":["YYKC-2021-01-001"]}]},{"name":"General project of Shanghai Natural Science Foundation","award":["22ZR1453100"],"award-info":[{"award-number":["22ZR1453100"]}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["21Y11921500"],"award-info":[{"award-number":["21Y11921500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"three-year action plan of shanghai traditional Chinese medicine","award":["2021-2023)-0201-06"],"award-info":[{"award-number":["2021-2023)-0201-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04608-8","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:19:45Z","timestamp":1761977985000},"page":"5399-5412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KAT6A regulates osteoclast differentiation and bone resorption through TET1-mediated TRPV4 expression"],"prefix":"10.1007","volume":"399","author":[{"given":"Boran","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianbo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"4608_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169465","author":"A Aibar-Almaz\u00e1n","year":"2022","unstructured":"Aibar-Almaz\u00e1n A, Voltes-Mart\u00ednez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcel\u00e9n-Fraile MDC, L\u00f3pez-Ruiz E (2022) Current status of the diagnosis and management of osteoporosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169465","journal-title":"Int J Mol Sci"},{"key":"4608_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-018-0387-5","volume":"560","author":"JB Baell","year":"2018","unstructured":"Baell JB, Leaver DJ, Hermans SJ, Kelly GL, Brennan MS, Downer NL, Nguyen N, Wichmann J, McRae HM, Yang Y, Cleary B, Lagiakos HR, Mieruszynski S, Pacini G, Vanyai HK, Bergamasco MI, May RE, Davey BK, Morgan KJ, Sealey AJ, Wang B, Zamudio N, Wilcox S, Garnham AL, Sheikh BN, Aubrey BJ, Doggett K, Chung MC, de Silva M, Bentley J, Pilling P, Hattarki M, Dolezal O, Dennis ML, Falk H, Ren B, Charman SA, White KL, Rautela J, Newbold A, Hawkins ED, Johnstone RW, Huntington ND, Peat TS, Heath JK, Strasser A, Parker MW, Smyth GK, Street IP, Monahan BJ, Voss AK, Thomas T (2018) Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth. Nature 560:253\u2013257","journal-title":"Nature"},{"key":"4608_CR3","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/550S15a","volume":"550","author":"C Brown","year":"2017","unstructured":"Brown C (2017) Osteoporosis: staying strong. Nature 550:S15-s17","journal-title":"Nature"},{"key":"4608_CR4","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/jbmr.3205","volume":"32","author":"X Cai","year":"2017","unstructured":"Cai X, Xing J, Long CL, Peng Q, Humphrey MB (2017) DOK3 modulates bone remodeling by negatively regulating osteoclastogenesis and positively regulating osteoblastogenesis. J Bone Miner Res 32:2207\u20132218","journal-title":"J Bone Miner Res"},{"key":"4608_CR5","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1002\/jcp.27432","volume":"234","author":"B Cao","year":"2019","unstructured":"Cao B, Dai X, Wang W (2019) Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca(2+) -calcineurin-NFATc1 pathway. J Cell Physiol 234:6831\u20136841","journal-title":"J Cell Physiol"},{"key":"4608_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jama.2017.21995","volume":"319","author":"KG Cotts","year":"2018","unstructured":"Cotts KG, Cifu AS (2018) Treatment of osteoporosis. JAMA 319:1040\u20131041","journal-title":"JAMA"},{"key":"4608_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18054-y","volume":"11","author":"S Damal Villivalam","year":"2020","unstructured":"Damal Villivalam S, You D, Kim J, Lim HW, Xiao H, Zushin PH, Oguri Y, Amin P, Kang S (2020) TET1 is a beige adipocyte-selective epigenetic suppressor of thermogenesis. Nat Commun 11:4313","journal-title":"Nat Commun"},{"key":"4608_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0875","author":"G Dixon","year":"2021","unstructured":"Dixon G, Pan H, Yang D, Rosen BP, Jashari T, Verma N, Pulecio J, Caspi I, Lee K, Stransky S, Glezer A, Liu C, Rivas M, Kumar R, Lan Y, Torregroza I, He C, Sidoli S, Evans T, Elemento O, Huangfu D (2021) QSER1 protects DNA methylation valleys from de novo methylation. Science. https:\/\/doi.org\/10.1126\/science.abd0875","journal-title":"Science"},{"key":"4608_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","volume":"12","author":"BM El-Masri","year":"2024","unstructured":"El-Masri BM, Andreasen CM, Laursen KS, Kofod VB, Dahl XG, Nielsen MH, Thomsen JS, Br\u00fcel A, S\u00f8rensen MS, Hansen LJ, Kim AS, Taylor VE, Massarotti C, McDonald MM, You X, Charles JF, Delaisse JM, Andersen TL (2024) Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res 12:62","journal-title":"Bone Res"},{"key":"4608_CR10","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC202401160","volume":"177","author":"KE Ensrud","year":"2024","unstructured":"Ensrud KE, Crandall CJ (2024) Osteoporosis. Ann Intern Med 177:Itc1\u2013Itc16","journal-title":"Ann Intern Med"},{"key":"4608_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13287-021-02164-5","volume":"12","author":"D Fei","year":"2021","unstructured":"Fei D, Wang Y, Zhai Q, Zhang X, Zhang Y, Wang Y, Li B, Wang Q (2021) KAT6A regulates stemness of aging bone marrow-derived mesenchymal stem cells through Nrf2\/ARE signaling pathway. Stem Cell Res Ther 12:104","journal-title":"Stem Cell Res Ther"},{"key":"4608_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pharmthera.2017.02.019","volume":"177","author":"MS Grace","year":"2017","unstructured":"Grace MS, Bonvini SJ, Belvisi MG, McIntyre P (2017) Modulation of the TRPV4 ion channel as a therapeutic target for disease. Pharmacol Ther 177:9\u201322","journal-title":"Pharmacol Ther"},{"key":"4608_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101513","volume":"12","author":"K Jabbari","year":"2025","unstructured":"Jabbari K, Khalafizadeh A, Sheikhbahaei M, Soltaninejad H, Babashah S (2025) TET1: the epigenetic architect of clinical disease progression. Genes Dis 12:101513","journal-title":"Genes Dis"},{"key":"4608_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2021.09.009","volume":"585","author":"Y Jin","year":"2021","unstructured":"Jin Y, Yang R, Ding J, Zhu F, Zhu C, Xu Q, Cai J (2021) KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochem Biophys Res Commun 585:185\u2013190","journal-title":"Biochem Biophys Res Commun"},{"key":"4608_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2013.08.032","volume":"79","author":"GA Kaas","year":"2013","unstructured":"Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, King JR, Song H, Sweatt JD (2013) TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79:1086\u20131093","journal-title":"Neuron"},{"key":"4608_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejphar.2011.04.062","volume":"663","author":"K Kato","year":"2011","unstructured":"Kato K, Morita I (2011) Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation: a study to elucidate the action points of acidosis and search for putative target molecules. Eur J Pharmacol 663:27\u201339","journal-title":"Eur J Pharmacol"},{"key":"4608_CR17","first-page":"33","volume":"7","author":"K Kato","year":"2013","unstructured":"Kato K, Morita I (2013) Promotion of osteoclast differentiation and activation in spite of impeded osteoblast-lineage differentiation under acidosis: effects of acidosis on bone metabolism. Biosci Trends 7:33\u201341","journal-title":"Biosci Trends"},{"key":"4608_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092073","author":"JM Kim","year":"2020","unstructured":"Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells. https:\/\/doi.org\/10.3390\/cells9092073","journal-title":"Cells"},{"key":"4608_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41419-021-03939-7","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu W, Yu Z, Zhang Y, Li Y, Xie D, Xie G, Fan L, He S (2021) A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-\u03baB pathways. Cell Death Dis 12:654","journal-title":"Cell Death Dis"},{"key":"4608_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cmet.2008.08.002","volume":"8","author":"R Masuyama","year":"2008","unstructured":"Masuyama R, Vriens J, Voets T, Karashima Y, Owsianik G, Vennekens R, Lieben L, Torrekens S, Moermans K, Vanden Bosch A, Bouillon R, Nilius B, Carmeliet G (2008) TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab 8:257\u2013265","journal-title":"Cell Metab"},{"key":"4608_CR21","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1038\/s41467-021-23735-3","volume":"12","author":"S Moyon","year":"2021","unstructured":"Moyon S, Frawley R, Marechal D, Huang D, Marshall-Phelps KLH, Kegel L, B\u00f8strand SMK, Sadowski B, Jiang YH, Lyons DA, M\u00f6bius W, Casaccia P (2021) TET1-mediated DNA hydroxymethylation regulates adult remyelination in mice. Nat Commun 12:3359","journal-title":"Nat Commun"},{"key":"4608_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7326\/M15-1361","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Forciea MA, McLean RM, Denberg TD, Barry MJ, Cooke M, Fitterman N, Harris RP, Humphrey LL, Kansagara D, McLean RM, Mir TP, Sch\u00fcnemann HJ (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166:818\u2013839","journal-title":"Ann Intern Med"},{"key":"4608_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","volume":"16","author":"IR Reid","year":"2020","unstructured":"Reid IR (2020) A broader strategy for osteoporosis interventions. Nat Rev Endocrinol 16:333\u2013339","journal-title":"Nat Rev Endocrinol"},{"key":"4608_CR24","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.2174\/156802611796904861","volume":"11","author":"F Vincent","year":"2011","unstructured":"Vincent F, Duncton MA (2011) TRPV4 agonists and antagonists. Curr Top Med Chem 11:2216\u20132226","journal-title":"Curr Top Med Chem"},{"key":"4608_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/nar\/gkac1188","volume":"51","author":"LM Weber","year":"2023","unstructured":"Weber LM, Jia Y, Stielow B, Gisselbrecht SS, Cao Y, Ren Y, Rohner I, King J, Rothman E, Fischer S, Simon C, Forn\u00e9 I, Nist A, Stiewe T, Bulyk ML, Wang Z, Liefke R (2023) The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain. Nucleic Acids Res 51:574\u2013594","journal-title":"Nucleic Acids Res"},{"key":"4608_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100729","volume":"53","author":"N Wiesel-Motiuk","year":"2020","unstructured":"Wiesel-Motiuk N, Assaraf YG (2020) The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Drug Resist Updat 53:100729","journal-title":"Drug Resist Updat"},{"key":"4608_CR27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","volume":"54","author":"BK Wu","year":"2022","unstructured":"Wu BK, Mei SC, Chen EH, Zheng Y, Pan D (2022) YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Nat Genet 54:1202\u20131213","journal-title":"Nat Genet"},{"key":"4608_CR28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/2159-8290.CD-20-1459","volume":"12","author":"F Yan","year":"2022","unstructured":"Yan F, Li J, Milosevic J, Petroni R, Liu S, Shi Z, Yuan S, Reynaga JM, Qi Y, Rico J, Yu S, Liu Y, Rokudai S, Palmisiano N, Meyer SE, Sung PJ, Wan L, Lan F, Garcia BA, Stanger BZ, Sykes DB, Blanco MA (2022) KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic gene-expression programs. Cancer Discov 12:792\u2013811","journal-title":"Cancer Discov"},{"key":"4608_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100014","volume":"8","author":"B Yu","year":"2021","unstructured":"Yu B, Luo F, Sun B, Liu W, Shi Q, Cheng SY, Chen C, Chen G, Li Y, Feng H (2021) KAT6A acetylation of SMAD3 regulates myeloid-derived suppressor cell recruitment, metastasis, and immunotherapy in triple-negative breast cancer. Adv Sci (Weinh) 8:e2100014","journal-title":"Adv Sci (Weinh)"},{"key":"4608_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/prd.12422","volume":"89","author":"B Yu","year":"2022","unstructured":"Yu B, Wang CY (2022) Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000 89:99\u2013113","journal-title":"Periodontol 2000"},{"key":"4608_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4155\/fmc-2020-0047","volume":"12","author":"C Zhou","year":"2020","unstructured":"Zhou C, Liu W, Duan Y (2020) MOZ\/KAT6A: a promising target for acute myeloid leukemia therapy. Future Med Chem 12:759\u2013761","journal-title":"Future Med Chem"},{"key":"4608_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1359\/jbmr.2002.17.7.1211","volume":"17","author":"W Zou","year":"2002","unstructured":"Zou W, Bar-Shavit Z (2002) Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211\u20131218","journal-title":"J Bone Miner Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04608-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T02:45:19Z","timestamp":1776221119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04608-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4608"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04608-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethic Committee of Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}